|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Tuveson DA and Jacks T: Modeling human
lung cancer in mice: similarities and shortcomings. Oncogene.
18:5318–5324. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Law SF, Estojak J, Wang B, et al: Human
enhancer of filamentation 1, a novel p130Cas-Like docking protein,
associates with FAK, and induces pseudohyphal growth in
Saccharomyces cerevisiae. Mol Cell Biol. 16:3327–3337.
1996.PubMed/NCBI
|
|
4
|
Minegishi M, Tachibana K, Sato T, et al:
Structure and function of Cas-L, a 105-kD Crk-associated
substrate-related protein that is involved in β-1 integrin-mediated
signaling in lymphocytes. J Exp Med. 184:1365–1375. 1996.PubMed/NCBI
|
|
5
|
Singh M, Cowell L, Seo S, et al: Molecular
basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator
of invasion, apoptosis and cell cycle. Cell Biochem Biophys.
48:54–72. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O’Neill GM, Seo S, Serebriiskii IG, et al:
A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
Cancer Res. 67:8975–8979. 2007.PubMed/NCBI
|
|
7
|
Tikhmyanova N, Little JL and Golemis EA:
CAS proteins in normal and pathological cell growth control. Cell
Mol Life Sci. 67:1025–1048. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Minn AJ, Gupta GP, Siegel PM, et al: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Natarajan M, Stewart JE, Golemis EA, et
al: HEF1 is a necessary and specific downstream effector of FAK
that promotes the migration of glioblastoma cells. Oncogene.
25:1721–1732. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim M, Gans JD, Nogueira C, et al:
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis
gene. Cell. 125:1269–1281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SH, Xia D, Dubois RN, et al: Human
enhancer of filamentation 1 is a mediator of hypoxia-inducible
factor-1α-mediated migration in colorectal carcinoma cells. Cancer
Res. 70:4054–4063. 2010.PubMed/NCBI
|
|
12
|
Thaole B, Vu HA, Yasuda K, et al: Cas-L
was overexpressed in imatinib-resistant gastrointestinal stromal
tumor cells. Cancer Biol Ther. 8:683–688. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang JX, Zhao GQ, Zhang GJ, et al:
Expression and clinical significance of NEDD9 in lung tissues. Med
Oncol. 29:2654–2660. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kondo S, Iwata S, Yamada T, et al: Impact
of the integrin signaling adaptor protein NEDD9 on prognosis and
metastatic behavior of human lung cancer. Clin Cancer Res.
18:6326–6338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng Y, Wang Y, Wang Z, et al: The
CRTC1-NEDD9 signaling axis mediates lung cancer progression caused
by LKB1 loss. Cancer Res. 72:6502–6511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miao Y, Li AL, Wang L, et al:
Overexpression of NEDD9 is associated with altered expression of
E-cadherin, β-catenin and N-cadherin and predictive of poor
prognosis in non-small cell lung cancer. Pathol Oncol Res.
19:281–286. 2013.PubMed/NCBI
|
|
17
|
Sen GL and Blau HM: A brief history of
RNAi: the silence of the genes. FASEB J. 20:1293–1299. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang JX, Zhao GQ, Zhang GJ, et al:
Construction and characterization of a eukaryotic expression vector
for small interfering RNA targeting the NEDD9 gene. Int J Mol Med.
30:1343–1348. 2012.PubMed/NCBI
|
|
19
|
Tanabe H, Yagihashi A, Tsuji N, et al:
Expression of survivin mRNA and livin mRNA in non-small-cell lung
cancer. Lung Cancer. 46:299–304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun BS, Dong QZ, Ye QH, et al:
Lentiviral-mediated miRNA against osteopontin suppresses tumor
growth and metastasis of human hepatocellular carcinoma.
Hepatology. 48:1834–1842. 2008. View Article : Google Scholar
|
|
21
|
Singh MK, Dadke D, Nicolas E, et al: A
novel Cas family member, HEPL, regulates FAK and cell spreading.
Mol Biol Cell. 19:1627–1636. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fashena SJ, Einarson MB, Golemis EA, et
al: Dissection of HEF1-dependent functions in motility and
transcriptional regulation. J Cell Sci. 115:99–111. 2002.PubMed/NCBI
|
|
23
|
Klemke RL, Leng J, Cheresh DA, et al:
CAS/Crk coupling serves as a ‘molecular switch’ for induction of
cell migration. J Cell Biol. 140:961–972. 1998.
|
|
24
|
Pugacheva EN and Golemis EA: The focal
adhesion scaffolding protein HEF1 regulates activation of the
Aurora-A and Nek2 kinases at the centrosome. Nat Cell Biol.
7:937–946. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dadke D, Jarnik M, Pugacheva EN, et al:
Deregulation of HEF1 impairs M-phase progression by disrupting the
RhoA activation cycle. Mol Biol Cell. 17:1204–1217. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seo S, Asai T, Saito T, et al:
Crk-associated substrate lymphocyte type is required for lymphocyte
trafficking and marginal zone B cell maintenance. J Immunol.
175:3492–3501. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elbashir SM, Harborth J, Lendeckel W, et
al: Duplexes of 21-nucleotide RNAs mediate RNA interference in
cultured mammalian cells. Nature. 411:494–498. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Echeverri CJ and Perrimon N:
High-throughput RNAi screening in cultured cells: a user’s guide.
Nat Rev Genet. 7:373–384. 2006.
|
|
29
|
Mofat J, Grueneberg DA, Yang X, et al: A
lentiviral RNAi library for human and mouse genes applied to an
arrayed viral high-content screen. Cell. 124:1283–1298. 2006.
View Article : Google Scholar : PubMed/NCBI
|
